These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

690 related items for PubMed ID: 15612519

  • 21. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids.
    Maurin AC, Chavassieux PM, Meunier PJ.
    Calcif Tissue Int; 2005 May; 76(5):385-92. PubMed ID: 15868283
    [Abstract] [Full Text] [Related]

  • 22. Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease.
    Keller JM, Collet P, Bianchi A, Huin C, Bouillaud-Kremarik P, Becuwe P, Schohn H, Domenjoud L, Dauça M.
    Int J Dev Biol; 2000 Aug; 44(5):429-42. PubMed ID: 11032176
    [Abstract] [Full Text] [Related]

  • 23. Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus.
    Viana Abranches M, Esteves de Oliveira FC, Bressan J.
    Nutr Hosp; 2011 Aug; 26(2):271-9. PubMed ID: 21666962
    [Abstract] [Full Text] [Related]

  • 24. Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors.
    Mandard S, Stienstra R, Escher P, Tan NS, Kim I, Gonzalez FJ, Wahli W, Desvergne B, Müller M, Kersten S.
    Cell Mol Life Sci; 2007 May; 64(9):1145-57. PubMed ID: 17437057
    [Abstract] [Full Text] [Related]

  • 25. [PPAR receptors: recent data].
    Vidal H.
    Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S5-9. PubMed ID: 15959399
    [Abstract] [Full Text] [Related]

  • 26. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?
    Grimaldi PA.
    Biochimie; 2005 Jan; 87(1):5-8. PubMed ID: 15733729
    [Abstract] [Full Text] [Related]

  • 27. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters.
    Bility MT, Thompson JT, McKee RH, David RM, Butala JH, Vanden Heuvel JP, Peters JM.
    Toxicol Sci; 2004 Nov; 82(1):170-82. PubMed ID: 15310864
    [Abstract] [Full Text] [Related]

  • 28. Molecular recognition of docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor alpha.
    Gani OA, Sylte I.
    J Mol Graph Model; 2008 Sep; 27(2):217-24. PubMed ID: 18547851
    [Abstract] [Full Text] [Related]

  • 29. [PPARs: structure, mechanisms of action and control. Note I].
    Filip-Ciubotaru F, Foia L, Manciuc C, Grigore C.
    Rev Med Chir Soc Med Nat Iasi; 2011 Sep; 115(2):477-84. PubMed ID: 21870744
    [Abstract] [Full Text] [Related]

  • 30. PPARgamma agonists and vascular risk factors: potential effects on cardiovascular disease.
    Asnani S, Theuma P, Fonseca VA.
    Metab Syndr Relat Disord; 2003 Mar; 1(1):23-32. PubMed ID: 18370623
    [Abstract] [Full Text] [Related]

  • 31. [The structures and functions of peroxisome proliferator-activated receptors (PPARs)].
    Takahashi N, Goto T, Kusudo T, Moriyama T, Kawada T.
    Nihon Rinsho; 2005 Apr; 63(4):557-64. PubMed ID: 15828220
    [Abstract] [Full Text] [Related]

  • 32. [The role of PPARs and their isoforms in metabolic disorders related to insulin resistance and diabetes].
    Kravchenko NA, Iarmysh NV.
    Tsitol Genet; 2011 Apr; 45(3):68-78. PubMed ID: 21774406
    [Abstract] [Full Text] [Related]

  • 33. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
    Guri AJ, Hontecillas R, Bassaganya-Riera J.
    J Nutrigenet Nutrigenomics; 2008 Apr; 1(3):126-35. PubMed ID: 19776622
    [Abstract] [Full Text] [Related]

  • 34. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
    Brown JD, Plutzky J.
    Circulation; 2007 Jan 30; 115(4):518-33. PubMed ID: 17261671
    [Abstract] [Full Text] [Related]

  • 35. [PPAR and diabetes].
    Terauchi Y, Kadowaki T.
    Nihon Rinsho; 2005 Apr 30; 63(4):623-9. PubMed ID: 15828230
    [Abstract] [Full Text] [Related]

  • 36. PPAR receptor activation: Experimental studies on cardiac structure and function.
    Bishop-Bailey D.
    Curr Opin Investig Drugs; 2010 Mar 30; 11(3):283-8. PubMed ID: 20178041
    [Abstract] [Full Text] [Related]

  • 37. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels.
    Yessoufou A, Wahli W.
    Swiss Med Wkly; 2010 Mar 30; 140():w13071. PubMed ID: 20842602
    [Abstract] [Full Text] [Related]

  • 38. The metabolic syndrome: relationship between insulin sensitivity and the role of peroxisome proliferator-activated receptors (PPARs) in saccharide and lipid metabolism.
    Yahia RB, Lichnovská R, Brychta T.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec 30; 149(2):237-41. PubMed ID: 16601762
    [Abstract] [Full Text] [Related]

  • 39. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
    Blaschke F, Takata Y, Caglayan E, Law RE, Hsueh WA.
    Arterioscler Thromb Vasc Biol; 2006 Jan 30; 26(1):28-40. PubMed ID: 16239592
    [Abstract] [Full Text] [Related]

  • 40. [PPARs, metabolic syndrome and cardiac diseases].
    Carvajal K, Hernández-Esquivel Mde L, Moreno-Sánchez R.
    Arch Cardiol Mex; 2007 Jan 30; 77 Suppl 4():S4-66-76. PubMed ID: 18938701
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.